RA Capital Management, a multi-stage investment manager company, and Andera Partners, an asset management firm, led a $118m Series B round in Mineralys Therapeutics, a private, clinical-stage biopharmaceutical company, with participation from RTW Investments, Rock Springs Capital, SR One Capital Management, Sectoral Asset Management, Ysios Capital, HealthCor Management, Boulder Ventures, Catalys Pacific, Samsara BioCapital, HBM Healthcare Investments and Adams Street Partners. “We are excited to have co-led this financing with Andera partners and look forward to helping Mineralys progress on the promise of MLS-101 for the treatment of hypertension,” Derek DiRocco, RA Capital Management Partner.